MYD88 mutations areslightly more frequent in marginal zone lymphoma (MZL) than CLL, but one of these two patients also harbored an SF3B1 mutation, which is far more frequent in CLL (Table S2). This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.